-
2020
- Publication of the book ⌜Radioimmunotherapy in KIRAMS⌟
- Holding a launching ceremony of KIRAMS Development Meeting
- Implementation of ‘research project about creating the radiation technology convergence cluster in capital area’
- Implementation E-learning on Radiation Medicine including Radiation Therapy
- Adoption of KIRAMS's international collaboration project as one of cooperation activities between Korea and IAEA
-
2 technology transfer
- Technology Transfer Agreement Signed for the MASTL Inhibitor Portfolio(DLpharma)
- Technology Transfer Agreement Signed for TED inhibitors(Boryung Pharmaceutical)
- KFDA apporoval for [64Cu]DOTA-rituximab microdosing clinical trial
- KFDA apporoval for phase 3 study of [18F]Florastamin PET in prostate cancer
-
2019
- Foundation for clinical research by researchers for diagnosis of brain diseases
-
6 technology transfers, 1 new drug venture start-up
- Radiosensitizer containing Aripiprazole as an effective ingredient (VSPharmTech) : Patent and Trademark Office Award on Korea Invention Patent Exhibition 2019
- SHVEA protein that increases the effectiveness of Huffis virus cell infection (Wellmarker Bio)
- Cell therapy techniques for treating wounds (biosolutions.co)
- Biomarker AROS Protein and Rictor (Gencellmed)
- Anti-cancer drug & Radiosensitizer Include beta-apophycroopyline (J&C Sciences)
- Development of MASTL - Based Tritic Breast Cancer Treatment Technologies (Dipharma)
- Selection of the first family business in 2019
-
2018
- Development of PET Radiopharmaceuticals for cervical cancer
- MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3
- miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP
- Study for Alzheimer Dementia using Diagnostic Radiopharmaceutical
- Evaluation index for Alzheimer Dementia using Diagnostic Radiopharmaceutical
- Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization
-
2017
- Clinical Trial Study for Alzheimer Dementia using Diagnostic Radiopharmaceutical
- Role of the p53/p21 complex, Bcl-2 family proteins, and respiratory complex I in the metastasis and recurrence of cancer cells
- Real-time monitoring of cellular proliferation in cancer using 19F MRI/MRS
- Radioimmunotherapy Overcomes Immunotherapy Resistant Head and Neck Squampus Cell Carcinoma
- Development and Clinical Trials of PET Radiopharmaceuticals for HER2 Positive Breast Cancer